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Abstract
Background: Sebaceous carcinoma is a rare malignancy primarily with aggressive growth affecting the cutaneous
tissues of the periocular region. Sebaceous carcinoma of the parotid gland is exceedingly rare, with only 32 cases
reported in the literature. Our case brings this total to 33.
Case presentation: We present a case of a 57-year-old Moroccan woman with a firm, painless, slowly enlarging
swelling at her left parotid area, with normal overlying skin and no palpable neck nodes. Parotidectomy with facial
nerve preservation was performed, and microscopic examination showed sebaceous carcinoma.
Then, she underwent adjuvant radiotherapy. With a follow up of 20 months, head and neck computed tomography
revealed no recurrence.
Conclusions: The optimal treatment is unclear. With more cases reported, clinicopathological characteristics and
histogenesis are increasingly understood. Therefore the treatment for this rare tumor continues to evolve.
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Background
Sebaceous carcinoma (SC) is a rare neoplasm with ag-
gressive growth. In 75 % of all cases [1] this tumor pre-
sents in the cutaneous tissues of the periocular region,
typically on the eyelid, but it has also been described less
commonly in other locations (70 % in the head and neck
region [1]), including as a primary tumor of the parotid
gland [2]. The parotid gland is the second most frequent
site for SC in the head and neck region [3].
In 1953, Foote and Frazell first reported in a review of
salivary gland tumors a case of sebaceous adenoma,
specifying that the listing of a single example of this
tumor type is more an anticipation, than a proof, of its
actual existence [4]. Six years later, Rauch and Masshoff
described a malignant counterpart (SC) in the parotid
gland [5]. Up to February 2015, there have been 32
documented cases of SC in the parotid gland [3, 6–28]
with our case bringing the total to 33. Its clinicopatho-
logical characteristics and histogenesis are not fully
understood because of its rarity.
We present a case of SC of the parotid gland with a
brief review of the literature.
Case presentation
A 57-year-old Moroccan woman with no tobacco smoking
history presented to an otolaryngology clinic with the chief
complaint being a lump over the left side of her parotid
region, for 9 months’ duration. Her anamnesis did not
reveal a similar case in her family. A physical examination
demonstrated a firm, painless, slowly enlarging swelling,
with normal overlying skin and no palpable neck nodes.
Ultrasonography of her neck revealed a 2.7 × 2.2 cm,
mixed component nodule with increased vascularity
(Fig. 1). Based on clinical and ultrasonography findings,
parotidectomy with facial nerve preservation was per-
formed without lymph node neck dissection.
Final pathology revealed a SC that was a low-grade
tumor. On macroscopic examination, the mass was ill de-
fined and white; it measured 1.5 × 2 cm. Microscopic exam-
ination demonstrated malignant proliferation composed of
cells organized in nests and bays, with moderate to marked
cytonuclear atypia, and a mixture of well-differentiated
sebocytes and atypical basaloid cells. Mitotic figures were
present (two to four per high-power field). No vascular
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invasion was demonstrated (Fig. 2). Immunohistochemistry
was not performed.
She was referred to our institution. We proposed a
lymph node dissection but she refused further surgery.
Postoperative computed tomography (CT) was per-
formed and confirmed no residual disease (Fig. 3) and
no neck nodes. A chest X-ray was also performed. There-
fore, she was classified stage II according to the seventh
edition of the American Joint Committee on Cancer’s
(AJCC) AJCC Cancer Staging Manual. She completed a
course of three-dimensional conformal radiation therapy,
indicated by the close margins, without chemotherapy.
Two oblique fields (6 MV) were used to deliver 66 Gy
with 2 Gy per fraction in parotid bed and an anterior field
(6 MV) to deliver 50Gy, 2Gy per a day to ipsilateral neck
lymph node (level II to IV).
With a follow up of 20 months, head and neck CT
revealed no recurrence and no adverse event was noted.
Discussion
Sebaceous glands are found in an estimated 10 to 40 % of
normal parotid glands and 6 to 10 % of submandibular
glands [29, 30]. However, malignant sebaceous salivary
gland tumors are extremely rare, making up less than 0.2 %
of all major salivary glands tumors [30]. In addition to par-
otid gland, salivary gland SC has been identified in the sub-
mandibular gland, oral cavity, sublingual gland, vallecula,
Fig. 1 Ultrasonography revealed a mixed component nodule of the left parotid
Fig. 2 Malignant proliferation composed of cells organized in nests and bays of different sizes, with moderate to marked cytonuclear atypia, and
a mixture of well-differentiated sebocytes and atypical basaloid cells
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epiglottis, and hypopharynx, totaling 47 SCs of salivary ori-
gin neoplasms [6].
These sebaceous elements appeared to originate from
the blind-ending intercalated and striated ducts. There is
also immunohistochemical evidence to show that SC origi-
nates from pluripotential duct cells; ultrastructural and im-
munohistochemical observations of the tumor revealed
coexistence of sebaceous and glandular differentiations in
some tumor cells. Tumor cells with lipid granules often
participated in the formation of glandular structures or
exhibited intracytoplasmic lumina, and immunohistochem-
ical localization of lactoferrin and secretory component, the
functional markers of ductal epithelium of salivary gland,
was demonstrated not only in duct-forming tumor cells but
also in many sebaceous tumor cells. It seems likely that SC
originates from pluripotential duct cells which can differen-
tiate into sebaceous, ductal, and mucous cells [24].
The age range of the affected patients was found to be
17 to 93 years, the maximum incidence for all the pri-
mary salivary gland sebaceous tumors occurred in the
sixth and seventh decades [20]. The sex ratio is 1:1 [11].
The patients often presented with a painless, slow-
growing, asymptomatic swelling, leading to delayed diag-
nosis or misdiagnosis. But some had experienced pain
and there were a few cases with facial paralyses [11].
On histological examination, SC ranged from 0.6 to
9.5 cm in greatest dimension and varied from yellow, tan-
white, grayish-white, white, to pale pink. The tumors are
frequently well circumscribed or partially encapsulated,
with pushing or locally infiltrating margins. Cellular
pleomorphism and cytologic atypia are uniformly present
and are much more prevalent than in sebaceous adenomas.
Tumor cells may be arranged in multiple variably sized
nests or in sheets and have hyperchromatic nuclei sur-
rounded by abundant clear vacuolated to eosinophilic
cytoplasm. Cellular pleomorphism and atypia varies from
mild to severe. Areas of cellular necrosis and fibrosis are
commonly found. Perineural invasion was observed in
more than 20 % of tumors, whereas vascular invasion was
extremely infrequent. Rare oncocytes and foreign body
giant cells with histiocytes may be observed, but lymphoid
tissue with follicles or subcapsular sinuses is not seen.
Identification of sebocytes is the key morphologic clue
to this entity, as is the absence of matrix protein typic-
ally seen in basal cell adenomas and pleomorphic aden-
omas. Neither the squamous component nor the goblet
cells of mucoepidermoid carcinoma are seen in SC, and a
mucin stain will be negative. SC does not show the cribri-
form growth pattern seen in adenoid cystic carcinoma,
and is less likely to show perineural invasion. Other un-
common tumors of the parotid with sebaceous differenti-
ation include sebaceous adenoma, which is usually sharply
circumscribed, sebaceous lymphadenoma, which contains
abundant lymphocytes, similar to a Warthin tumor, and
sebaceous lymphadenocarcinoma, which shows adjacent
areas of typical sebaceous lymphadenoma [29].
Fig. 3 Postoperative computed tomography scan showing no residual tissue in parotid space
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Because of its rarity, a conclusion regarding optimal ther-
apy for this malignancy is lacking. However, treatment is
based on surgery with wide surgical excision for low-grade
and low-stage carcinomas. Adjunctive radiation therapy is
recommended for higher stage and higher grade tumors
but also in the case of positive margins. Radical parotidect-
omy and elective neck dissection should be considered for
tumors with marked cytologic atypia or involvement of the
facial nerve [6].
SCs may recur and they will rarely metastasize; at least six
cases of SC of the salivary glands have been described with
local recurrence and metastasis [31]. The overall 5-year sur-
vival rate is 62 %, significantly less than the survival rate for
similar tumors arising in the skin and orbit (84.5 %) [32].
Conclusions
With more cases reported, clinicopathological characteris-
tics and histogenesis are increasingly understood. There-
fore the treatment for this rare tumor continues to evolve.
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